INS and type 1 diabetes mellitus: In addition to insulin replacement therapy, β-cell replacement using either allogenic solid organ pancreas or islet transplantation has demonstrated the potential to reverse T1D but necessitates lifelong immunosuppression to prevent graft rejection [5].